Boston Therapeutics Inc.

The company just got the permission to submit PAZAMET as Abriviation New Drug Application with the FDA with no additional clinical trials.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location United States
  • Currency USD
  • Founded August 2009
  • Employees 7
  • Website bostonti.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free